Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa
- PMID: 3391625
- DOI: 10.1177/096032718800700308
Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa
Abstract
1. The metabolic oxidation of debrisoquine has been studied in a group of 96 San Bushmen. 2. The amounts of debrisoquine and 4-hydroxy-debrisoquine excreted in 0-8 h urine were measured and the metabolic ratio (% dose as debrisoquine/% dose as 4-hydroxy-debrisoquine) calculated. 3. On the basis of Caucasian criteria, that metabolic ratios greater than 12.6 represent poor metabolizers, 19% of the Bushmen were poor metabolizers in contrast to the 8-10% found in Caucasian studies. 4. Probit plots showed four modes may be present in the data, which may represent at least three isozymes of the relevant enzyme which may also differ from the Caucasian isozymes.
Similar articles
-
Metoprolol alpha-hydroxylation polymorphism in the San Bushmen of southern Africa.Hum Toxicol. 1989 Jan;8(1):39-43. doi: 10.1177/096032718900800107. Hum Toxicol. 1989. PMID: 2714809
-
Non-correlation between debrisoquine and metoprolol polymorphisms in the Venda.Hum Toxicol. 1989 Sep;8(5):365-8. doi: 10.1177/096032718900800506. Hum Toxicol. 1989. PMID: 2807305
-
Polymorphism of debrisoquine 4-hydroxylation and family studies of poor metabolizers in Chinese population.Zhongguo Yao Li Xue Bao. 1990 Jan;11(1):7-10. Zhongguo Yao Li Xue Bao. 1990. PMID: 2403020
-
The genetic polymorphism of debrisoquine/sparteine metabolism-molecular mechanisms.Pharmacol Ther. 1990;46(2):297-308. doi: 10.1016/0163-7258(90)90096-k. Pharmacol Ther. 1990. PMID: 2181495 Review.
-
The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.Clin Pharmacokinet. 1986 Jan-Feb;11(1):1-17. doi: 10.2165/00003088-198611010-00001. Clin Pharmacokinet. 1986. PMID: 2868819 Review.
Cited by
-
Dextromethorphan O-demethylation polymorphism in Jordanians.Eur J Clin Pharmacol. 1993;45(3):271-3. doi: 10.1007/BF00315395. Eur J Clin Pharmacol. 1993. PMID: 8276053
-
Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort.Pharmacogenomics J. 2016 Nov;16(6):566-572. doi: 10.1038/tpj.2015.76. Epub 2015 Oct 27. Pharmacogenomics J. 2016. PMID: 26503815
-
African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.EBioMedicine. 2017 Mar;17:67-74. doi: 10.1016/j.ebiom.2017.02.017. Epub 2017 Feb 20. EBioMedicine. 2017. PMID: 28237373 Free PMC article.
-
Oxidative polymorphism of dextromethorphan in a Burundi population.Eur J Clin Pharmacol. 1991;41(1):75-7. doi: 10.1007/BF00280112. Eur J Clin Pharmacol. 1991. PMID: 1782983
-
Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations.Discov Med. 2013 Sep;16(87):113-22. Discov Med. 2013. PMID: 23998447 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources